Skip to main content
Erschienen in: Memetic Computing 4/2020

30.10.2020 | Regular Research Paper

Designing optimal combination therapy for personalised glioma treatment

verfasst von: Nasimul Noman, Pablo Moscato

Erschienen in: Memetic Computing | Ausgabe 4/2020

Einloggen

Aktivieren Sie unsere intelligente Suche, um passende Fachinhalte oder Patente zu finden.

search-config
loading …

Abstract

Background

Like it happens in other tumours, glioma cells co-evolve in a microenvironment consisting of bona fide tumour cells as well as a range of parenchymal cells, which produces numerous signalling molecules. Recently, the results of an in silico experiment suggested that a combination therapy that would target multiple key cytokines at the same time may be more effective for suppressing the growth of a tumour. The in silico experiments also showed that the optimal combination therapy is very much dependent on a patient’s molecular profile.

Method

In this work, we employ evolutionary algorithms for designing optimal combination therapy tailored to the patient’s tumour microenvironment. Experiments were performed using a state-of-the-art glioma microenvironment model, capable of imitating many characteristics of human glioma development, and many virtual patient profiles.

Conclusions

Results show that the therapies designed by the presented memetic algorithm were very effective in impeding tumour growth and were tailored to the patient’s personal tumour microenvironment.

Sie haben noch keine Lizenz? Dann Informieren Sie sich jetzt über unsere Produkte:

Springer Professional "Wirtschaft+Technik"

Online-Abonnement

Mit Springer Professional "Wirtschaft+Technik" erhalten Sie Zugriff auf:

  • über 102.000 Bücher
  • über 537 Zeitschriften

aus folgenden Fachgebieten:

  • Automobil + Motoren
  • Bauwesen + Immobilien
  • Business IT + Informatik
  • Elektrotechnik + Elektronik
  • Energie + Nachhaltigkeit
  • Finance + Banking
  • Management + Führung
  • Marketing + Vertrieb
  • Maschinenbau + Werkstoffe
  • Versicherung + Risiko

Jetzt Wissensvorsprung sichern!

Springer Professional "Technik"

Online-Abonnement

Mit Springer Professional "Technik" erhalten Sie Zugriff auf:

  • über 67.000 Bücher
  • über 390 Zeitschriften

aus folgenden Fachgebieten:

  • Automobil + Motoren
  • Bauwesen + Immobilien
  • Business IT + Informatik
  • Elektrotechnik + Elektronik
  • Energie + Nachhaltigkeit
  • Maschinenbau + Werkstoffe




 

Jetzt Wissensvorsprung sichern!

Springer Professional "Wirtschaft"

Online-Abonnement

Mit Springer Professional "Wirtschaft" erhalten Sie Zugriff auf:

  • über 67.000 Bücher
  • über 340 Zeitschriften

aus folgenden Fachgebieten:

  • Bauwesen + Immobilien
  • Business IT + Informatik
  • Finance + Banking
  • Management + Führung
  • Marketing + Vertrieb
  • Versicherung + Risiko




Jetzt Wissensvorsprung sichern!

Anhänge
Nur mit Berechtigung zugänglich
Fußnoten
1
The PSO version in the jMetal framework http://​jmetal.​sourceforge.​net/​ was used.
 
2
The basic ABC version available from https://​abc.​erciyes.​edu.​tr/​software.​htm was used.
 
Literatur
1.
Zurück zum Zitat Abdallah MB, Blonski M, Wantz-Mezieres S, Gaudeau Y, Taillandier L, Moureaux JM, Darlix A, de Champfleur NM, Duffau H (2019) Data-driven predictive models of diffuse low-grade gliomas under chemotherapy. IEEE J Biomed Health Inf 23(1):38–46CrossRef Abdallah MB, Blonski M, Wantz-Mezieres S, Gaudeau Y, Taillandier L, Moureaux JM, Darlix A, de Champfleur NM, Duffau H (2019) Data-driven predictive models of diffuse low-grade gliomas under chemotherapy. IEEE J Biomed Health Inf 23(1):38–46CrossRef
2.
Zurück zum Zitat Agarwal S, Lakoma A, Chen Z, Hicks J, Metelitsa LS, Kim ES, Shohet JM (2015) G-CSF promotes neuroblastoma tumorigenicity and metastasis via STAT3-dependent cancer stem cell activation. Cancer Res 75(12):2566–2579CrossRef Agarwal S, Lakoma A, Chen Z, Hicks J, Metelitsa LS, Kim ES, Shohet JM (2015) G-CSF promotes neuroblastoma tumorigenicity and metastasis via STAT3-dependent cancer stem cell activation. Cancer Res 75(12):2566–2579CrossRef
4.
Zurück zum Zitat Calzolari D, Bruschi S, Coquin L, Schofield J, Feala JD, Reed JC, McCulloch AD, Paternostro G (2008) Search algorithms as a framework for the optimization of drug combinations. PLoS Comput Biol 4(12):e1000249CrossRef Calzolari D, Bruschi S, Coquin L, Schofield J, Feala JD, Reed JC, McCulloch AD, Paternostro G (2008) Search algorithms as a framework for the optimization of drug combinations. PLoS Comput Biol 4(12):e1000249CrossRef
5.
Zurück zum Zitat Chheda MG, Wen PY, Hochberg FH, Chi AS, Drappatz J, Eichler AF, Yang D, Beroukhim R, Norden AD, Gerstner ER et al (2015) Vandetanib plus sirolimus in adults with recurrent glioblastoma: results of a phase I and dose expansion cohort study. J Neurooncol 121(3):627–634CrossRef Chheda MG, Wen PY, Hochberg FH, Chi AS, Drappatz J, Eichler AF, Yang D, Beroukhim R, Norden AD, Gerstner ER et al (2015) Vandetanib plus sirolimus in adults with recurrent glioblastoma: results of a phase I and dose expansion cohort study. J Neurooncol 121(3):627–634CrossRef
6.
Zurück zum Zitat Cloughesy TF, Mochizuki AY, Orpilla JR, Hugo W, Lee AH, Davidson TB, Wang AC, Ellingson BM, Rytlewski JA, Sanders CM et al (2019) Neoadjuvant anti-PD-1 immunotherapy promotes a survival benefit with intratumoral and systemic immune responses in recurrent glioblastoma. Nat Med 25(3):477–486CrossRef Cloughesy TF, Mochizuki AY, Orpilla JR, Hugo W, Lee AH, Davidson TB, Wang AC, Ellingson BM, Rytlewski JA, Sanders CM et al (2019) Neoadjuvant anti-PD-1 immunotherapy promotes a survival benefit with intratumoral and systemic immune responses in recurrent glioblastoma. Nat Med 25(3):477–486CrossRef
7.
Zurück zum Zitat Colman H, Aldape K (2008) Molecular predictors in glioblastoma: toward personalized therapy. Arch Neurol 65(7):877–883CrossRef Colman H, Aldape K (2008) Molecular predictors in glioblastoma: toward personalized therapy. Arch Neurol 65(7):877–883CrossRef
8.
Zurück zum Zitat Colombo MC, Giverso C, Faggiano E, Boffano C, Acerbi F, Ciarletta P (2015) Towards the personalized treatment of glioblastoma: integrating patient-specific clinical data in a continuous mechanical model. PLoS ONE 10(7):e0132887CrossRef Colombo MC, Giverso C, Faggiano E, Boffano C, Acerbi F, Ciarletta P (2015) Towards the personalized treatment of glioblastoma: integrating patient-specific clinical data in a continuous mechanical model. PLoS ONE 10(7):e0132887CrossRef
9.
Zurück zum Zitat Cruickshanks N, Zhang Y, Yuan F, Pahuski M, Gibert M, Abounader R (2017) Role and therapeutic targeting of the HGF/MET pathway in glioblastoma. Cancers 9(7):87CrossRef Cruickshanks N, Zhang Y, Yuan F, Pahuski M, Gibert M, Abounader R (2017) Role and therapeutic targeting of the HGF/MET pathway in glioblastoma. Cancers 9(7):87CrossRef
10.
Zurück zum Zitat Das S, Suganthan PN (2011) Differential evolution: a survey of the state-of-the-art. IEEE Trans Evol Comput 15(1):4–31CrossRef Das S, Suganthan PN (2011) Differential evolution: a survey of the state-of-the-art. IEEE Trans Evol Comput 15(1):4–31CrossRef
11.
Zurück zum Zitat Fitzgerald JB, Schoeberl B, Nielsen UB, Sorger PK (2006) Systems biology and combination therapy in the quest for clinical efficacy. Nat Chem Biol 2(9):458–466CrossRef Fitzgerald JB, Schoeberl B, Nielsen UB, Sorger PK (2006) Systems biology and combination therapy in the quest for clinical efficacy. Nat Chem Biol 2(9):458–466CrossRef
12.
Zurück zum Zitat Ge SG, Xia J, Sha W, Zheng CH (2017) Cancer subtype discovery based on integrative model of multigenomic data. IEEE/ACM Trans Comput Biol Bioinf 14(5):1115–1121CrossRef Ge SG, Xia J, Sha W, Zheng CH (2017) Cancer subtype discovery based on integrative model of multigenomic data. IEEE/ACM Trans Comput Biol Bioinf 14(5):1115–1121CrossRef
13.
Zurück zum Zitat Godlewski J, Krichevsky AM, Johnson MD, Chiocca EA, Bronisz A (2014) Belonging to a network–microRNAs, extracellular vesicles, and the glioblastoma microenvironment. Neuro Oncol 17(5):652–662CrossRef Godlewski J, Krichevsky AM, Johnson MD, Chiocca EA, Bronisz A (2014) Belonging to a network–microRNAs, extracellular vesicles, and the glioblastoma microenvironment. Neuro Oncol 17(5):652–662CrossRef
14.
Zurück zum Zitat Greco F, Vicent MJ (2009) Combination therapy: opportunities and challenges for polymer-drug conjugates as anticancer nanomedicines. Adv Drug Deliv Rev 61(13):1203–1213CrossRef Greco F, Vicent MJ (2009) Combination therapy: opportunities and challenges for polymer-drug conjugates as anticancer nanomedicines. Adv Drug Deliv Rev 61(13):1203–1213CrossRef
15.
Zurück zum Zitat Han J, Alvarez-Breckenridge CA, Wang QE, Yu J (2015) TGF-\(\beta \) signaling and its targeting for glioma treatment. Am J Cancer Res 5(3):945–955 Han J, Alvarez-Breckenridge CA, Wang QE, Yu J (2015) TGF-\(\beta \) signaling and its targeting for glioma treatment. Am J Cancer Res 5(3):945–955
16.
Zurück zum Zitat Karaboga D, Basturk B (2008) On the performance of artificial bee colony (ABC) algorithm. Appl Soft Comput 8(1):687–697CrossRef Karaboga D, Basturk B (2008) On the performance of artificial bee colony (ABC) algorithm. Appl Soft Comput 8(1):687–697CrossRef
17.
Zurück zum Zitat Li G, Qin Z, Chen Z, Xie L, Wang R, Zhao H (2017) Tumor microenvironment in treatment of glioma. Open Med 12(1):247–251CrossRef Li G, Qin Z, Chen Z, Xie L, Wang R, Zhao H (2017) Tumor microenvironment in treatment of glioma. Open Med 12(1):247–251CrossRef
18.
Zurück zum Zitat Moscato P, Cotta C (2019) An accelerated introduction to memetic algorithms. In: Gendreau M, Potvin JY (eds) Handbook of metaheuristics. Springer, Berlin, pp 275–309CrossRef Moscato P, Cotta C (2019) An accelerated introduction to memetic algorithms. In: Gendreau M, Potvin JY (eds) Handbook of metaheuristics. Springer, Berlin, pp 275–309CrossRef
19.
Zurück zum Zitat Poli R, Kennedy J, Blackwell T (2007) Particle swarm optimization. Swarm Intell 1(1):33–57CrossRef Poli R, Kennedy J, Blackwell T (2007) Particle swarm optimization. Swarm Intell 1(1):33–57CrossRef
20.
Zurück zum Zitat Qi L, Yu H, Zhang Y, Zhao D, Lv P, Zhong Y, Xu Y (2016) IL-10 secreted by M2 macrophage promoted tumorigenesis through interaction with JAK2 in glioma. Oncotarget 7(44):71673–71685CrossRef Qi L, Yu H, Zhang Y, Zhao D, Lv P, Zhong Y, Xu Y (2016) IL-10 secreted by M2 macrophage promoted tumorigenesis through interaction with JAK2 in glioma. Oncotarget 7(44):71673–71685CrossRef
21.
Zurück zum Zitat Rape A, Ananthanarayanan B, Kumar S (2014) Engineering strategies to mimic the glioblastoma microenvironment. Adv Drug Deliv Rev 79–80:172–183CrossRef Rape A, Ananthanarayanan B, Kumar S (2014) Engineering strategies to mimic the glioblastoma microenvironment. Adv Drug Deliv Rev 79–80:172–183CrossRef
22.
Zurück zum Zitat Salacz ME, Kast RE, Saki N, Brüning A, Karpel-Massler G, Halatsch ME (2016) Toward a noncytotoxic glioblastoma therapy: blocking MCP-1 with the MTZ regimen. OncoTargets Therapy 9:2535–2545CrossRef Salacz ME, Kast RE, Saki N, Brüning A, Karpel-Massler G, Halatsch ME (2016) Toward a noncytotoxic glioblastoma therapy: blocking MCP-1 with the MTZ regimen. OncoTargets Therapy 9:2535–2545CrossRef
23.
Zurück zum Zitat Storn R, Price K (1997) Differential evolution-a simple and efficient heuristic for global optimization over continuous spaces. J Global Optim 11(4):341–359MathSciNetCrossRef Storn R, Price K (1997) Differential evolution-a simple and efficient heuristic for global optimization over continuous spaces. J Global Optim 11(4):341–359MathSciNetCrossRef
24.
Zurück zum Zitat Sun L, Hui AM, Su Q, Vortmeyer A, Kotliarov Y, Pastorino S, Passaniti A, Menon J, Walling J, Bailey R et al (2006) Neuronal and glioma-derived stem cell factor induces angiogenesis within the brain. Cancer Cell 9(4):287–300CrossRef Sun L, Hui AM, Su Q, Vortmeyer A, Kotliarov Y, Pastorino S, Passaniti A, Menon J, Walling J, Bailey R et al (2006) Neuronal and glioma-derived stem cell factor induces angiogenesis within the brain. Cancer Cell 9(4):287–300CrossRef
25.
Zurück zum Zitat Tarassishin L, Lim J, Weatherly DB, Angeletti RH, Lee SC (2014) Interleukin-1-induced changes in the glioblastoma secretome suggest its role in tumor progression. J Proteomics 99:152–168CrossRef Tarassishin L, Lim J, Weatherly DB, Angeletti RH, Lee SC (2014) Interleukin-1-induced changes in the glioblastoma secretome suggest its role in tumor progression. J Proteomics 99:152–168CrossRef
26.
Zurück zum Zitat Tong D, Liu Q, Wang La, Xie Q, Pang J, Huang Y, Wang L, Liu G, Zhang D, Lan W et al (2018) The roles of the COX2/PGE2/EP axis in therapeutic resistance. Cancer Metastasis Rev 37(2–3):355–368CrossRef Tong D, Liu Q, Wang La, Xie Q, Pang J, Huang Y, Wang L, Liu G, Zhang D, Lan W et al (2018) The roles of the COX2/PGE2/EP axis in therapeutic resistance. Cancer Metastasis Rev 37(2–3):355–368CrossRef
28.
Zurück zum Zitat Wang H, Xu T, Jiang Y, Xu H, Yan Y, Fu D, Chen J (2015) The challenges and the promise of molecular targeted therapy in malignant gliomas. Neoplasia 17(3):239–255CrossRef Wang H, Xu T, Jiang Y, Xu H, Yan Y, Fu D, Chen J (2015) The challenges and the promise of molecular targeted therapy in malignant gliomas. Neoplasia 17(3):239–255CrossRef
29.
Zurück zum Zitat Weller M, Stupp R, Hegi M, Wick W (2012) Individualized targeted therapy for glioblastoma: fact or fiction? Cancer J 18(1):40–44CrossRef Weller M, Stupp R, Hegi M, Wick W (2012) Individualized targeted therapy for glioblastoma: fact or fiction? Cancer J 18(1):40–44CrossRef
30.
Zurück zum Zitat Wu Y, Lu Y, Chen W, Fu J, Fan R (2012) In silico experimentation of glioma microenvironment development and anti-tumor therapy. PLoS Comput Biol 8(2):e1002355MathSciNetCrossRef Wu Y, Lu Y, Chen W, Fu J, Fan R (2012) In silico experimentation of glioma microenvironment development and anti-tumor therapy. PLoS Comput Biol 8(2):e1002355MathSciNetCrossRef
31.
Zurück zum Zitat Zhu VF, Yang J, LeBrun DG, Li M (2012) Understanding the role of cytokines in glioblastoma multiforme pathogenesis. Cancer Lett 316(2):139–150CrossRef Zhu VF, Yang J, LeBrun DG, Li M (2012) Understanding the role of cytokines in glioblastoma multiforme pathogenesis. Cancer Lett 316(2):139–150CrossRef
Metadaten
Titel
Designing optimal combination therapy for personalised glioma treatment
verfasst von
Nasimul Noman
Pablo Moscato
Publikationsdatum
30.10.2020
Verlag
Springer Berlin Heidelberg
Erschienen in
Memetic Computing / Ausgabe 4/2020
Print ISSN: 1865-9284
Elektronische ISSN: 1865-9292
DOI
https://doi.org/10.1007/s12293-020-00312-7

Weitere Artikel der Ausgabe 4/2020

Memetic Computing 4/2020 Zur Ausgabe

Premium Partner